India · Delayed Price · Currency is INR Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 252.21 billion. The enterprise value is 254.46 billion.
| Market Cap | 252.21B |
| Enterprise Value | 254.46B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
| Current Share Class | 12.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 11.30% |
| Owned by Institutions (%) | 24.28% |
| Float | 7.36M |
Valuation Ratios
The trailing PE ratio is 55.62 and the forward PE ratio is 46.90.
| PE Ratio | 55.62 |
| Forward PE | 46.90 |
| PS Ratio | 10.90 |
| PB Ratio | 12.43 |
| P/TBV Ratio | 14.45 |
| P/FCF Ratio | 97.76 |
| P/OCF Ratio | 33.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.13, with an EV/FCF ratio of 98.63.
| EV / Earnings | 56.23 |
| EV / Sales | 11.00 |
| EV / EBITDA | 36.13 |
| EV / EBIT | 41.57 |
| EV / FCF | 98.63 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.25 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 1.33 |
| Interest Coverage | 26.59 |
Financial Efficiency
Return on equity (ROE) is 24.80% and return on invested capital (ROIC) is 22.64%.
| Return on Equity (ROE) | 24.80% |
| Return on Assets (ROA) | 13.75% |
| Return on Invested Capital (ROIC) | 22.64% |
| Return on Capital Employed (ROCE) | 25.39% |
| Weighted Average Cost of Capital (WACC) | 5.79% |
| Revenue Per Employee | 10.60M |
| Profits Per Employee | 2.07M |
| Employee Count | 2,183 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, NSE:NEULANDLAB has paid 1.56 billion in taxes.
| Income Tax | 1.56B |
| Effective Tax Rate | 25.67% |
Stock Price Statistics
The stock price has increased by +14.34% in the last 52 weeks. The beta is 0.28, so NSE:NEULANDLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +14.34% |
| 50-Day Moving Average | 21,518.16 |
| 200-Day Moving Average | 17,468.34 |
| Relative Strength Index (RSI) | 41.84 |
| Average Volume (20 Days) | 48,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 23.14 billion and earned 4.53 billion in profits. Earnings per share was 352.74.
| Revenue | 23.14B |
| Gross Profit | 12.71B |
| Operating Income | 6.12B |
| Pretax Income | 6.09B |
| Net Income | 4.53B |
| EBITDA | 7.04B |
| EBIT | 6.12B |
| Earnings Per Share (EPS) | 352.74 |
Balance Sheet
The company has 4.50 billion in cash and 3.42 billion in debt, with a net cash position of 1.08 billion.
| Cash & Cash Equivalents | 4.50B |
| Total Debt | 3.42B |
| Net Cash | 1.08B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.30B |
| Book Value Per Share | 1,582.09 |
| Working Capital | 7.71B |
Cash Flow
In the last 12 months, operating cash flow was 7.45 billion and capital expenditures -4.87 billion, giving a free cash flow of 2.58 billion.
| Operating Cash Flow | 7.45B |
| Capital Expenditures | -4.87B |
| Depreciation & Amortization | 920.76M |
| Net Borrowing | 804.11M |
| Free Cash Flow | 2.58B |
| FCF Per Share | n/a |
Margins
Gross margin is 54.94%, with operating and profit margins of 26.46% and 19.56%.
| Gross Margin | 54.94% |
| Operating Margin | 26.46% |
| Pretax Margin | 26.31% |
| Profit Margin | 19.56% |
| EBITDA Margin | 30.44% |
| EBIT Margin | 26.46% |
| FCF Margin | 11.15% |
Dividends & Yields
This stock pays an annual dividend of 34.00, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 34.00 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | 183.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.64% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.18% |
| Earnings Yield | 1.80% |
| FCF Yield | 1.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:NEULANDLAB is 24,828.50, which is 26.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24,828.50 |
| Price Target Difference | 26.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 20.11% |
| EPS Growth Forecast (3Y) | 31.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |